Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case–control study

Abstract

Oral glucocorticoid use was identified as a risk factor for heart failure. However, the evidence remains observational and only a randomised controlled trial of glucocorticoid treatment versus other disease modifying agents is likely to distinguish the importance of the underlying disease activity from its treatment in predicting cardiovascular outcomes.